Chord gets $16m to challenge Alexion with oral NMOSD drug

Swiss biotech Chord Therapeutics has come out of stealth mode with a $16 million first-round financing that will be used to progress a repurposed drug for rare disease neuromyelitis optica

$110m financing sets up US, Asia expansion for Sophia Geneti...

Swiss medical data specialist Sophia Genetics has raised $110 million in an oversubscribed funding round that will be used to boost its headcount and international presence and prepare to t

Digital health firm Lyra enters unicorn territory after fund...

Digital health startup Lyra Health has raised $110 million in fourth-round financing, raising its value above the $1 billion threshold for the first time since it was founded f

UK cancer mutation testing firm Biofidelity raises $12m

Cambridge, UK-based Biofidelity has raised $12 million in first-round funding for its cancer diagnosis platform, which can detect mutations quicker than current approaches

Novo-backed $61m fundraising helps F2G prep for antifungal l...

Anglo-Austrian biotech F2G has raised $60.8 million in venture financing to help it bring a drug for life-threatening fungal infections through late-stage development and onto

UK biotech OMass raises £27.5m for GPCR drug discovery